To clarify whether the clinical response after the first 2 cycles with Onabotulinumtoxin A can accurately predict the long-term response.
Vernieri F., Paolucci M., Altamura C., Pasqualetti P., Mastrangelo V., Pierangeli G., et al. (2019). Onabotulinumtoxin-A in Chronic Migraine: Should Timing and Definition of Non-Responder Status Be Revised? Suggestions From a Real-Life Italian Multicenter Experience. HEADACHE, 59(8), 1300-1309 [10.1111/head.13617].
Onabotulinumtoxin-A in Chronic Migraine: Should Timing and Definition of Non-Responder Status Be Revised? Suggestions From a Real-Life Italian Multicenter Experience
Mastrangelo V.;Pierangeli G.;Cevoli S.;
2019
Abstract
To clarify whether the clinical response after the first 2 cycles with Onabotulinumtoxin A can accurately predict the long-term response.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
